Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 8/20 | 0.50 |
| ▸ | CTSS | P25774 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | TGM2 | P21980 | 1/20 | 0.44 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12643955 | 1.00 | FOLH1 (0.58) | FOLH1MEN1GAAKMT2ACTSK | |
| SCHEMBL7718173 | 1.00 | FOLH1 (0.58) | FOLH1MEN1GAAKMT2ACTSK | |
| SCHEMBL1373885 | 0.96 | MEN1 (0.59) | FOLH1MEN1GAAKMT2ACTSK | |
| SCHEMBL1373880 | 0.96 | MEN1 (0.59) | FOLH1MEN1GAAKMT2ACTSK | |
| SCHEMBL391537 | 0.91 | MEN1 (0.65) | FOLH1MEN1GAAKMT2ACTSK | |
| SCHEMBL10241524 | 0.91 | MEN1 (0.65) | FOLH1MEN1GAAKMT2ACTSK | |
| SCHEMBL3445777 | 0.91 | MEN1 (0.65) | FOLH1MEN1GAAKMT2ACTSK | |
| Hydrochloric Acid SCHEMBL28881882 | 0.90 | MEN1 (0.63) | FOLH1MEN1GAAKMT2ACTSK | |
| SCHEMBL21702752 | 0.90 | MEN1 (0.63) | FOLH1MEN1GAAKMT2ACTSK | |
| SCHEMBL20143076 | 0.90 | MEN1 (0.55) | FOLH1MEN1GAAKMT2ACTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120114563-A | Biotin tripeptide with hair growth function and composition, preparation method and application thereof | 天津科技大学 | 2025-06-10 | — | — | CN | claimed |
| CN-116253770-B | Gemcitabine prodrug with double activation of HDAC and CTSL as well as preparation method and application thereof | 山东省科学院生物研究所 | 2024-12-17 | — | — | CN | claimed |
| CN-117800910-A | Double-lock An Nai Pht anticancer prodrug AcKLP and preparation method and application thereof | 南京师范大学 | 2024-04-02 | — | — | CN | claimed |
| CN-116253770-A | Gemcitabine prodrug with double activation of HDAC and CTSL as well as preparation method and application thereof | 山东省科学院生物研究所 | 2023-06-13 | — | — | CN | claimed |
| CN-113041361-B | Diagnosis and treatment integrated material responding to HDAC and CTSL and preparation method and application thereof | 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） | 2022-08-16 | — | — | CN | claimed |
| CN-116583303-B | Tripterine conjugates and uses thereof | 瑞阳公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| US-20250339542-A1 | CONVERSION OF A BIOLOGICALLY SILENT MIRNA BINDING SMALL MOLECULE TO AN MIRNA DEGRADER | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250304645-A1 | Prodrugs of GLP-1 Polypeptide and Uses Thereof | NOVO NORDISK A/S (DK) | 2025-10-02 | — | — | US | disclosed |
| CN-120114563-A | Biotin tripeptide with hair growth function and composition, preparation method and application thereof | 天津科技大学 | 2025-06-10 | — | — | CN | disclosed |
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
| EP-4522220-A1 | PRODRUGS OF GLP-1 POLYPEPTIDE AND USES THEREOF | Novo Nordisk A/S (DK) | 2025-03-19 | — | — | EP | disclosed |
| EP-1389616-B1 | 3,4-Dihalobenzylpiperidine derivatives and their medical use | MITSUBISHI TANABE PHARMA CORP (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-20110082208-A1 | THERAPIES FOR CANCER USING ISOTOPICALLY SUBSTITUTED LYSINE | BIOJIVA LLC | 2011-04-07 | — | — | US | disclosed |
| US-7115635-B2 | Benzylpiperidine compound | MITSUBISHI PHARMA CORPORATION (JP) | 2006-10-03 | — | — | US | disclosed |
| US-20040158071-A1 | Chemokine inhibitors and stability in blood | MITSUBISHI PHARMA CORPORATION (JP) | 2004-08-12 | — | — | US | disclosed |
| EP-1389616-A1 | NOVEL BENZYLPIPERIDINE COMPOUND | Mitsubishi Pharma Corporation (JP) | 2004-02-18 | — | — | EP | disclosed |
| US-6127341-A | AMINOMETHYL-N-(1-((2-(2-THIENYL)-1-(1-CARBAMOYL-5 -AMINOPENTYLCARBAMOYL)ETHYL)-N-METHYLCARBAMOYL)-2-(2 -NAPTHYL)ETHYL)BENZAMIDE, FOR EXAMPLE; ADMINISTERING TO STIMULATE GROWTH, MILK OR WOOL PRODUCTION IN ANIMALS | NOVO NORDISK A/S (DK) | 2000-10-03 | — | — | US | disclosed |
| EP-1005484-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 2000-06-07 | — | — | EP | disclosed |
| WO-1998058950-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1998-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082208-A1 | THERAPIES FOR CANCER USING ISOTOPICALLY SUBSTITUTED LYSINE | AADAT, DOT1L, TP53 | FOLH1 7/4885MEN1 1390/4885GAA 1146/4885 |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | FOLH1 2368/4885MEN1 4664/4885GAA 2026/4885 |
| US-20250339542-A1 | CONVERSION OF A BIOLOGICALLY SILENT MIRNA BINDING SMALL MOLECULE TO AN MIRNA DEGRADER | NSUN3, AGO2, ZFR | FOLH1 1779/4885MEN1 1716/4885GAA 849/4885 |
| US-20040158071-A1 | Chemokine inhibitors and stability in blood | CCL2, CXCR1, CCR5 | FOLH1 918/4885MEN1 3525/4885GAA 3114/4885 |
| US-20250304645-A1 | Prodrugs of GLP-1 Polypeptide and Uses Thereof | GLP1R, IAPP, GCG | FOLH1 56/4885MEN1 480/4885GAA 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.